Accessibility Menu

Cryosite

(ASX) CTE

Current PriceA$1.06
Market CapA$51.74M
Since IPO (2002)+328%
5 Year+241%
1 Year+41%
1 Month-1%

Cryosite Financials at a Glance

Market Cap

A$51.74M

Revenue (TTM)

A$28.60M

Net Income (TTM)

A$4.02M

EPS (TTM)

A$0.04

P/E Ratio

23.66

Dividend

A$0.00

Beta (Volatility)

-0.21 (Low)

Price

A$1.06

Volume

0

Open

A$1.06

Previous Close

A$1.06

Daily Range

A$1.06 - A$1.06

52-Week Range

A$0.66 - A$1.30

Estimated Earnings Date

Feb 18, 2026

CTE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cryosite

Industry

Life Sciences Tools and Services

Employees

25

CEO

John Hogg

Headquarters

South Granville, NSW 2142, AU

CTE Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

19%

Net Income Margin

14%

Return on Equity

89%

Return on Capital

19%

Return on Assets

8%

Earnings Yield

4.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$51.74M

Shares Outstanding

48.81M

Volume

0

Avg. Volume

3.87K

Financials (TTM)

Gross Profit

A$8.89M

Operating Income

A$2.50M

EBITDA

A$3.41M

Operating Cash Flow

A$2.06M

Capital Expenditure

-A$586.00K

Free Cash Flow

A$1.48M

Cash & ST Invst.

A$5.06M

Total Debt

A$2.27M

Cryosite Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$8.27M

+29.2%

Gross Profit

A$4.65M

+30.6%

Gross Margin

56.26%

N/A

Market Cap

A$51.74M

N/A

Market Cap/Employee

A$2.07M

N/A

Employees

25

N/A

Net Income

A$1.14M

+34.5%

EBITDA

A$1.93M

+34.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$2.54M

-57.2%

Total Debt

A$8.82M

+249.0%

Accounts Receivable

A$2.59M

+31.9%

Inventory

A$72.00K

-18.2%

Long Term Debt

A$1.96M

-58.4%

Short Term Debt

A$6.86M

+3934.7%

Return on Assets

8.23%

N/A

Return on Invested Capital

19.36%

N/A

Free Cash Flow

-A$2.35M

-317.5%

Operating Cash Flow

A$1.30M

+2.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CMP.AXCompumedics Limited
A$0.24-2.04%
RAD.AXRadiopharm Theranostics Limited
A$0.02+5.26%
DOC.AXDoctor Care Anywhere Group PLC
A$0.12+0.00%
CYP.AXCynata Therapeutics Limited
A$0.26+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%

Questions About CTE

What is the current price of Cryosite?

Cryosite is trading at A$1.06 per share.

What is the 52-week range for Cryosite?

Over the past 52 weeks, Cryosite has traded between A$0.66 and A$1.30.

How much debt does Cryosite have?

As of the most recent reporting period, Cryosite reported total debt of A$2.27M.

How much cash does Cryosite have on hand?

Cryosite reported A$5.06M in cash and cash equivalents in its most recent financial results.

What is Cryosite’s dividend yield?

Cryosite does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.